HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series].

AbstractBACKGROUND AND OBJECTIVES:
The causal treatment of chronic pruritus is not always possible or effective necessitating symptomatic antipruritic therapy. Antihistamines are the only drugs approved for the treatment of chronic pruritus, but they are rarely effective at standard doses. The aim of this investigation was to describe the efficacy and safety of high-dosage antihistamine treatment in patients with chronic pruritus of different origin.
PATIENTS:
A total of 67 patients with chronic pruritus caused by different skin diseases or chronic pruritus of unknown origin were treated with levocetirizine 10 mg/fexofenadine 360 mg or levocetirizine 10 mg/fexofenadine 360 mg/azelastine 4 mg or desloratadine 20 mg per day.
RESULTS:
A therapeutic response was achieved in 43.8% of patients with a combination of two antihistamines, 68.4% of patients with three antihistamines and 76.9% of patients with high dosage desloratadine. The average reduction in pruritus was 57.5% (two antihistamines), 67.4% (three antihistamines) and 89% (desloratadine). Adverse drug effects were observed rarely.
CONCLUSIONS:
The results of this case series suggest a high antipruritic effect in chronic pruritus by administration of high-dosage, non-sedating antihistamines. These results have to be confirmed in controlled trials. The combination was not more effective than the high dosage monotherapy. The latter one might be preferable due to unknown interactions and addition of side-effects in the combination therapy.
AuthorsS Schulz, M Metz, D Siepmann, T A Luger, M Maurer, S Ständer
JournalDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete (Hautarzt) Vol. 60 Issue 7 Pg. 564-8 (Jul 2009) ISSN: 1432-1173 [Electronic] Germany
Vernacular TitleAntipruritische Wirksamkeit einer hoch dosierten Antihistaminikatherapie. Ergebnisse einer retrospektiv analysierten Fallserie.
PMID19430742 (Publication Type: Controlled Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Antipruritics
  • Histamine Antagonists
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antipruritics (administration & dosage)
  • Case-Control Studies
  • Chronic Disease
  • Dose-Response Relationship, Drug
  • Histamine Antagonists (administration & dosage)
  • Humans
  • Middle Aged
  • Pruritus (diagnosis, drug therapy)
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: